Next Article in Journal
Online Near-Infrared Spectroscopy for the Measurement of Cow Milk Quality in an Automatic Milking System
Previous Article in Journal
Experimental Investigation of Two- and Three-Blade Savonius Hydrokinetic Turbine for Hydropower Applications: A Study across Various Turbine Positions from Channel Centre to Channel Wall
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Confinement–Segregation Theory to Explain the Formation Mechanism of Peptide-Containing Particles in Metered Dose Inhalers †

1
College of Pharmacy, Jinan University, Guangzhou 510632, China
2
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510275, China
*
Authors to whom correspondence should be addressed.
Presented at the 4th International Electronic Conference on Applied Sciences, 27 October–10 November 2023; Available online: https://asec2023.sciforum.net/.
These authors contributed equally to this work.
Eng. Proc. 2023, 56(1), 143; https://doi.org/10.3390/ASEC2023-16355
Published: 27 November 2023
(This article belongs to the Proceedings of The 4th International Electronic Conference on Applied Sciences)

Abstract

:
Understanding how to formulate peptides into metered dose inhalers (MDIs) is a bottleneck issue hampering the clinical translation of relevant products. In our previous studies, a bottom–up method to prepare peptide-containing particles for MDIs was reported. Nevertheless, the formation mechanism of the particles remains unclear. In this work, considering the production workflow, a confinement–segregation theory was put forward as a hypothesis to explain the formation mechanism. Confinement and segregation were two major processes during formation, and their definitions are provided in detail. Based on the theory, some factors influencing particle formation were also discussed, which promoted future formulation design. It is believed that the proposed theory will provide new insights into the study of peptide-containing MDIs and boost their clinical translation.

1. Introduction

Metered dose inhalers (MDIs) are promising delivery systems for peptides due to their rapid adsorption rate, high patient compliance, and low cost [1]. However, the clinical translation of peptide-containing MDIs has not yet been witnessed. This is because formulating peptides with propellant (HFA 134a or HFA 227) [2], a hydrophobic material that is immiscible with most peptides [3], is a complicated task. To facilitate the clinical translation, our group established a bottom–up approach to preparing peptide-containing MDIs [4]. Briefly, peptides and lecithin were dissolved in the aqueous and organic phases, respectively. The aqueous phase was added to the organic phase under the vortex. The system was snap-frozen with liquid nitrogen and then lyophilized. The lyophilizate was washed with an organic solvent to remove excess lecithin and centrifuged to harvest the particles. Ultimately, the particles were suspended in the filled propellant to obtain MDIs. Furthermore, thymopentin was employed as a model peptide for MDI production, and the product possessed high uniformity, lung deposition ratio, and storage stability, which meant it was qualified for general clinical use [5].

2. Hypothesis

The feasibility of the established preparation method has been demonstrated by previous studies. Nevertheless, the formation mechanism of peptide-containing particles is not explicated. Without a clear understanding of this mechanism, we cannot control the potential factors to formulate a wider scope of peptides [6].
Herein, a confinement–segregation theory is put forward to explain the formation mechanism of peptide-containing particles, after referring to the related literature [7,8,9,10]. Literally, confinement and segregation are the two critical processes, which are extracted from the above preparation workflow and defined as follows.
I. Confinement process. (1) This involves the construction of a reverse-phase crude emulsion. Peptide aqueous solution and lecithin organic solution act as the inner phase and outer phase, respectively. Lecithin with surface activity constructs an emulsification layer between the two phases [11]. (2) There is an equilibrium of forces to offer a confinement effect. During snap freezing, water in the inner phase converts into ice crystals with expanded volume [12]. Thus, an expanding force vectoring to the outer phase is generated. Correspondingly, lecithin in the emulsification layer imposes a surface tension vectoring to the inner phase. The equilibrium of both counterparts results in a limited size for freezing nucleation. (3) Formation of the transient zone occurs. This is induced mutually by the expanding force and surface tension, where neighboring peptide and lecithin molecules near the emulsification layer collide with each other and yield non-covalent interactions [13]. Subsequently, a transient non-covalent polymer zone is generated.
II. Segregation process. (1) This involves the yielding of an in situ void. During the freeze-drying process, ice crystals in the initial inner phase sublime under extremely low pressure [14], and the volume previously occupied by them turns into a void. In this context, the initial expanding force fades, and the induction force for the transient non-covalent polymer zone becomes insufficient. (2) Next is the segregation of peptides into two microphases. With a substantially reduced induction force, a predominant proportion of non-covalent polymer dissociates, and the free peptides return to the bulk peptide region. At a low temperature, the molecular chains of peptides in this region are folded, and a chain-folded crystal core is formed [15]. Meanwhile, a minor proportion of non-covalent polymers maintain the structure through peptide–lecithin interaction. These species further consolidate into a thin peptide–lecithin ‘self-preservation’ surface [16]. Noticeably, peptides segregate into two microphases, i.e., a chain-folded crystal core and a ‘self-preservation’ surface. (3) Next is the removal of excess lecithin. Since merely a minor proportion of non-covalent polymer is preserved, most lecithin molecules are unbonded. Washing the system with organic solvent dissolves the free lecithin [17].
The above theory is schematically illustrated in Figure 1. After undergoing confinement and segregation processes, peptide-containing particles are obtained. A restricted freezing nucleation scope and a solidified particle are successively acquired by these two processes. It is worth mentioning that, with the help of the peptide–lecithin ‘self-preservation’ surface, particles can be stably suspended in the hydrophobic propellant, as the hydrophobic moieties of lecithin increase the miscibility with propellant [18].

3. Consequence of Hypothesis

With this proposed theory, we can figure out the factors influencing the formation process of peptide-containing particles and take advantage of them for future formulation design and development [19]. Based on the above rationale, we preliminarily provide one reasonable example here, per one process.

3.1. Snap Freezing Rate in Confinement Process

The equilibrium of expanding force and surface tension determines the size for freezing nucleation that, in turn, dominates the size of the obtained particles, and the expanding force is further determined by the snap freezing rate. As can be expected, a faster rate will result in a faster expansion of ice crystals, and finally a greater expanding force. By adjusting the snap freezing rate, one can probably control the size of the particles.

3.2. Peptide-Lecithin Interaction Force in the Segregation Process

Such a force determines the proportion of non-covalent polymer that is maintained, and then the thickness of the ‘self-preservation’ surface. Since the ‘self-preservation’ surface is crucial for stabilizing peptide-containing particles in the propellant, one should match the peptide–lecithin pair with a suitable interaction force.
Hence, under research and development, the snap freezing rate and peptide–lecithin interaction force are worthy of consideration. Formulation screening and optimization should be conducted to find the optimal parameters, according to our theory.

4. Conclusions

After a survey of the relevant documents, a confinement–segregation theory was put forward in this paper to explain the formation mechanism of peptide-containing particles, which were intended for MDI preparation. We will perform experimental validation based on this theory in ongoing studies, using a variety of model peptides. In addition, the significance of tuning the snap freezing rate and peptide–lecithin interaction force will be examined.

Author Contributions

Conceptualization, W.W. and P.L.; methodology, W.W.; software, P.L.; validation, P.L.; formal analysis, W.W.; investigation, P.L.; resources, W.W.; data curation, W.W.; writing—original draft preparation, P.L.; writing—review and editing, Z.H.; visualization, P.L.; supervision, X.P.; project administration, C.W.; funding acquisition, Z.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China, grant number 82104070.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kumar, R.; Mehta, P.; Shankar, K.R.; Rajora, M.A.; Mishra, Y.K.; Mostafavi, E.; Kaushik, A. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications. Pharm. Res. 2022, 39, 2831–2855. [Google Scholar] [CrossRef] [PubMed]
  2. Jadhav, P.; Patil, P.; Bhagwat, D.; Gaikwad, V.; Mehta, P.P. Recent advances in orthogonal analytical techniques for microstructural understanding of inhalable particles: Present status and future perspective. J. Drug Deliv. Sci. Technol. 2022, 68, 103089. [Google Scholar] [CrossRef]
  3. Vora, D.; Dandekar, A.A.; Banga, A.K. Therapeutic Peptide Delivery: Fundamentals, Formulations, and Recent Advances. Pept. Ther. 2022, 47, 183–201. [Google Scholar]
  4. Tan, Y.; Yang, Z.; Peng, X.; Xin, F.; Xu, Y.; Feng, M.; Zhao, C.; Hu, H.; Wu, C. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants. Int. J. Pharm. 2011, 413, 167–173. [Google Scholar] [CrossRef] [PubMed]
  5. Tan, Y.; Yang, Z.; Pan, X.; Chen, M.; Feng, M.; Wang, L.; Liu, H.; Shan, Z.; Wu, C. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process. Int. J. Pharm. 2012, 427, 385–392. [Google Scholar] [CrossRef] [PubMed]
  6. Rawat, P.; Gupta, S. Dual engineered gold nanoparticle based synergistic prophylaxis delivery system for HIV/AIDS. Med. Hypotheses 2021, 150, 110576. [Google Scholar] [CrossRef] [PubMed]
  7. Kojima, S.; Nagata, F.; Kugimiya, S.; Kato, K. Synthesis of peptide-containing calcium phosphate nanoparticles exhibiting highly selective adsorption of various proteins. Appl. Surf. Sci. 2018, 458, 438–445. [Google Scholar] [CrossRef]
  8. Huang, Z.; Wu, H.; Yang, B.; Chen, L.; Huang, Y.; Quan, G.; Zhu, C.; Li, X.; Pan, X.; Wu, C. Anhydrous reverse micelle nanoparticles: New strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers. Drug Deliv. 2017, 24, 527–538. [Google Scholar] [CrossRef] [PubMed]
  9. Hashemzadeh, H.; Javadi, H.; Darvishi, M. Study of Structural stability and formation mechanisms in DSPC and DPSM liposomes: A coarse-grained molecular dynamics simulation. Sci. Rep. 2020, 10, 1–10. [Google Scholar] [CrossRef] [PubMed]
  10. Wu, G.; Hui, X.; Liang, J.; Liu, H.; Chen, H.; Gong, X.; Brennan, M.A.; Zeng, X.A.; Guo, X.; Brennan, C.S. Combination of rehydrated whey protein isolate aqueous solution with blackcurrant concentrate and the formation of encapsulates via spray-drying and freeze-drying: Alterations to the functional properties of protein and their anticancer properties. Food Chem. 2021, 355, 129620. [Google Scholar] [CrossRef] [PubMed]
  11. Wu, F.; Chen, F.; Pu, Y.; Qian, F.; Leng, Y.; Mu, G.; Zhu, X. Effects of soy lecithin concentration on the physicochemical properties of whey protein isolate, casein-stabilised simulated infant formula emulsion and their corresponding microcapsules. Int. J. Dairy Technol. 2022. [Google Scholar] [CrossRef]
  12. Piaggi, P.M.; Panagiotopoulos, A.Z.; Debenedetti, P.G.; Car, R. Phase equilibrium of water with hexagonal and cubic ice using the scan functional. J. Chem. Theory Comput. 2021, 17, 3065–3077. [Google Scholar] [CrossRef] [PubMed]
  13. Flores, J.; White, B.M.; Brea, R.J.; Baskin, J.M.; Devaraj, N.K. Lipids: Chemical tools for their synthesis, modification, and analysis. Chem. Soc. Rev. 2020, 49, 4602–4614. [Google Scholar] [CrossRef] [PubMed]
  14. Luo, C.; Liu, Z.; Mi, S.; Li, L. Quantitative investigation on the effects of ice crystal size on freeze-drying: The primary drying step. Dry. Technol. 2022, 40, 446–458. [Google Scholar] [CrossRef]
  15. Davidov, G.; Abelya, G.; Zalk, R.; Izbicki, B.; Shaibi, S.; Spektor, L.; Shagidov, D.; Meyron-Holtz, E.G.; Zarivach, R.; Frank, G.A. Folding of an intrinsically disordered iron-binding peptide in response to sedimentation revealed by cryo-EM. J. Am. Chem. Soc. 2020, 142, 19551–19557. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, L.; Tao, G.H.; Xu, C.M.; Zhang, G.H.; He, L. Self-Assembled Biomimetic Capsules for Self-Preservation. Small 2020, 16, 2000930. [Google Scholar] [CrossRef] [PubMed]
  17. Hills, B. Possible role of adsorbed surfactant in controlling membrane permeability and function. Med. Hypotheses 1989, 28, 85–92. [Google Scholar] [CrossRef] [PubMed]
  18. Sommerville, M.L.; Cain, J.B.; Johnson, C.S., Jr.; Hickey, A.J. Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants. Pharm. Dev. Technol. 2000, 5, 219–230. [Google Scholar] [CrossRef] [PubMed]
  19. Rani, P.; Kapoor, B.; Gulati, M.; Gupta, R. Nanoscale self-assembling prodrugs of sulfapyridine for treatment of arthritis: Harnessing the dual approach. Med. Hypotheses 2022, 165, 110896. [Google Scholar] [CrossRef]
Figure 1. Scheme for confinement–segregation theory. Definition of abbreviations: IP, inner phase; OP, outer phase; SF, snap freezing; FD, freeze drying; and T, temperature.
Figure 1. Scheme for confinement–segregation theory. Definition of abbreviations: IP, inner phase; OP, outer phase; SF, snap freezing; FD, freeze drying; and T, temperature.
Engproc 56 00143 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Luo, P.; Wang, W.; Wu, C.; Pan, X.; Huang, Z. Confinement–Segregation Theory to Explain the Formation Mechanism of Peptide-Containing Particles in Metered Dose Inhalers. Eng. Proc. 2023, 56, 143. https://doi.org/10.3390/ASEC2023-16355

AMA Style

Luo P, Wang W, Wu C, Pan X, Huang Z. Confinement–Segregation Theory to Explain the Formation Mechanism of Peptide-Containing Particles in Metered Dose Inhalers. Engineering Proceedings. 2023; 56(1):143. https://doi.org/10.3390/ASEC2023-16355

Chicago/Turabian Style

Luo, Peili, Wenhao Wang, Chuanbin Wu, Xin Pan, and Zhengwei Huang. 2023. "Confinement–Segregation Theory to Explain the Formation Mechanism of Peptide-Containing Particles in Metered Dose Inhalers" Engineering Proceedings 56, no. 1: 143. https://doi.org/10.3390/ASEC2023-16355

Article Metrics

Back to TopTop